Qiang Xia, MD., Ph.D.
Dept. Liver Surgery, Renji Hospital, School of Medicine, SJTU
1
0
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
No phase data
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (1)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Hao Feng, MD., Ph.D.
Dept. Liver Surgery, Renji Hospital, School of Medicine, SJTU
Shared therapeutic areas:
Worked with same sponsors:
David Calatayud Mizrahi, MD, PhD
Hospital Universitari i Politècnic La Fe, Valencia
Shared therapeutic areas:
Wanguang Zhang, M.D.
Tongji Hospital
Shared therapeutic areas:
Qiang Xia
Dept. Liver Surgery, Renji Hospital, School of Medicine, SJTU
Shared therapeutic areas:
Worked with same sponsors:
Rafael López Andújar, MD, PhD
Hospital Universitari i Politècnic La Fe, Valencia
Shared therapeutic areas:
David Wojciechowski, DO
University of Texas Southwestern Medical Center
Shared therapeutic areas:
Şerafettin OKUTAN, PhD.
Bitlis Eren University
Shared therapeutic areas:
xuehao wang
The First Affiliated Hospital with Nanjing Medical University
Shared therapeutic areas:
Maria A Cebrià i Iranzo, PT, PhD
Hospital Universitari i Politècnic La Fe, Valencia
Shared therapeutic areas:
Martín Prieto Castillo, MD, PhD
Hospital Universitari i Politècnic La Fe, Valencia
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Pembrolizumab and LENvatinib in Participants With Hepatocellular Carcinoma (HCC) Before Liver Transplant
All 1 trials loaded